Hepatocellular carcinoma: a new hope?

References

[1] Spieler B,Jones PD.Stereotactic ablative radiotherapy for hepatocellular carcinoma..Hepatoma Res2019;5:4

[2] Stereotactic body (SBRT) followedy by immunotherapy in liver cancer. NCT 03203304. Clinicaltrials.gov

[3] Mehta A,Portelance L.Congenital absence of the portal vein complicated by hepatocellular carcinoma in the liver of an adult woman: review of imaging, literature and management..Hepatoma Res2018;4:7

[4] Ayoub WS,Martin P.The impact of nucleos(t)ide analog therapy in hepatitis B on the incidence of hepatocellular carcinoma: an update including recent literature findings..Hepatoma Res2017;3:302-8

[5] Feun LG,Wangpaichitr M,Savaraj N.Immunotherapy for hepatocellular carcinoma: the force awakens in HCC?.Hepatoma Res2017;3:43-51

[6] Kaseb A,Vence LM,Singh S.Randomized, open-label, perioperative phase II study evaluating nivolumab alone or nivolumab plus ipilimumab in patients with resectable HCC..J Clin Oncol2019;37:abstr4098